HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JIUYUAN GENE

5.100

+0.0100.20%

Volume:10.00K

Turnover:50.96K

Market Cap:1.22B

PE:7.75

High:5.105

Open:5.100

Low:5.100

Close:5.090

52wk High:15.424

52wk Low:4.600

Shares:240.00M

HK Float Shares:240.00M

Volume Ratio:0.20

T/O Rate:0.00%

Dividend:0.07

Dividend Rate:1.30%

EPS(LYR):0.658

ROE:8.50%

ROA:4.30%

PB:0.62

PE(LYR):7.75

PS:0.81

Loading ...

Overview Company News Filings

Hangzhou Jiuyuan Gene says CSRC clears H-share full circulation filing for 136.3 million shares

Stable 10.6% Margin At Hangzhou Jiuyuan Genetic Biopharmaceutical Reinforces Bullish Valuation Narratives

Simply Wall St.

Stock Track | JIUYUAN GENE Plummets 5.08% Intraday on Weak FY25 Results with Revenue Decline

JIUYUAN GENE (02566) Proposes Appointment of Dr. Huang Wenli as Independent Non-Executive Director

JIUYUAN GENE (02566) Announces Annual Results: Profit Attributable to Owners Reaches RMB 138 Million, Proposes Final Dividend of RMB 0.57 per 10 Shares

Jiuyuan Gene Updates Board Governance Framework with Revised Nomination Committee Charter Effective March 2026

Bulletin Express

Hangzhou Jiuyuan Gene proposes final dividend of RMB 0.57 per 10 shares

Hangzhou Jiuyuan FY25 revenue falls 4.6% to RMB 1.3 billion

Jiuyuan Gene targets 31.13% public float through 136.30 million-share H-share conversion

Bulletin Express

Hangzhou Jiuyuan Gene Engineering; public float rises to about 31.13% due to planned H-share full circulation pending CSRC filing notice by end-April 2026

JIUYUAN GENE Withdraws 2026 Share Award Scheme Resolutions and Cancels 8 Apr Extraordinary General Meeting

Bulletin Express

Jiuyuan Gene (02566.HK) Sets 30 Mar 2026 Board Meeting for FY2025 Results and Dividend Review

Bulletin Express

Hangzhou Jiuyuan Genetic Biopharmaceutical to hold board meeting on 2025 audited results and final dividend proposal

JIUYUAN GENE's JY47 Injection Receives Implied Clinical Trial Approval from NMPA

Jiuyuan Gene (02566) Secures NMPA IND Approval for SIRPα-Targeting JY47 Injection in MASH with Liver Fibrosis

Bulletin Express

Hangzhou Jiuyuan Gene Engineering wins NMPA clinical trial approval for JY47 injection IND

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy47 Injection Ind Application Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS

Hangzhou Jiuyuan Gene Engineering Co. Ltd. Announces Extraordinary General Meeting Notice

JIUYUAN GENE (02566) Reports February 2026 Share Repurchases and Updated Public Float

Bulletin Express

JIUYUAN GENE (02566) Releases February 2026 Monthly Return on Equity Movements

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02566/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02566","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"JIUYUAN GENE","latestPrice":5.1,"timestamp":1787299687019,"preClose":5.09,"halted":0,"volume":10000,"delay":0,"changeRate":0.001964636542239644,"floatShares":240000000,"shares":240000000,"eps":0.6579857489807439,"marketStatus":"Not Yet Opened","change":0.01,"latestTime":"08-21 16:08:07","open":5.1,"high":5.105,"low":5.1,"amount":50964,"amplitude":0.000982,"askPrice":5.4,"askSize":2000,"bidPrice":5.1,"bidSize":12200,"shortable":0,"etf":0,"ttmEps":0.6679988900771499,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":5.09,"dividendRate":0.013007,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.19920318740972365,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","floatShares":240000000,"roa":"4.30%","roe":"8.50%","lyrEps":0.657986,"volumeRatio":0.19920318740972365,"shares":240000000,"dividePrice":0.066498,"high":5.105,"amplitude":0.000982,"preClose":5.09,"low":5.1,"week52Low":4.6,"pbRate":"0.62","psRate":"0.81","week52High":15.424,"institutionHeld":0,"latestPrice":5.1,"committee":0.71831,"eps":0.6579857489807439,"divideRate":0.013039,"volume":10000,"delay":0,"ttmEps":0.6679988900771499,"open":5.1,"prevYearClose":7.475,"prevWeekClose":5.1,"prevMonthClose":5.36,"prevQuarterClose":5.9,"fiveDayClose":5.41,"twentyDayClose":5.07,"sixtyDayClose":6.229,"dividendFrequency":"A","dividendGrowthYears":0,"fiveYearAvgDividendRate":0.008171466845277964},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02566\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-06-17","symbol":"02566","amount":0.057,"announcedDate":"2026-03-30","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-06-18","defaultRemindTime":1781659800000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-30","payableDate":"2026-06-18","currency":"CNY","dateTimestamp":1781625600000,"payDate":"2026-07-30"},{"date":"2026-03-30","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-18","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-06-13","symbol":"02566","amount":0.056,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-16","defaultRemindTime":1749778200000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-06-16","currency":"CNY","dateTimestamp":1749744000000,"payDate":"2025-07-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02566\",market:\"HK\",,,undefined,":[{"executeDate":"2025-06-13","recordDate":"2025-06-16","paymentDate":"2025-07-30","value":0.056,"currency":"CNY"},{"executeDate":"2026-06-17","recordDate":"2026-06-18","paymentDate":"2026-07-30","value":0.057,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02566\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02566\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02566","date":"2026-08-21","current":7.633025,"percent":0.002381,"low":7.557391,"twenty":10.071221,"median":12.803792,"eighty":16.5966,"high":28.852596,"avg":13.530617,"sd":4.356127,"marketCap":1231733640},"quantilePoints":[{"date":"2024-12-06","current":14.097915,"twenty":14.208262,"median":14.275695,"eighty":14.595644,"marketCap":1946012484},{"date":"2024-12-13","current":13.217326,"twenty":13.348436,"median":13.95821,"eighty":14.334483,"marketCap":1820859096},{"date":"2024-12-20","current":12.20261,"twenty":12.40882,"median":13.381214,"eighty":14.243818,"marketCap":1673619816},{"date":"2024-12-27","current":12.158366,"twenty":12.254449,"median":13.1954,"eighty":14.180675,"marketCap":1666257852},{"date":"2025-01-03","current":11.126814,"twenty":12.0799,"median":12.46117,"eighty":14.042033,"marketCap":1526380536},{"date":"2025-01-10","current":9.714633,"twenty":11.141125,"median":12.29741,"eighty":13.763077,"marketCap":1327607508},{"date":"2025-01-17","current":9.904165,"twenty":10.518129,"median":12.180488,"eighty":13.509332,"marketCap":1354601376},{"date":"2025-01-24","current":10.07429,"twenty":9.9409,"median":12.04207,"eighty":13.348436,"marketCap":1386503220},{"date":"2025-01-28","current":10.358786,"twenty":9.995541,"median":11.819979,"eighty":13.282881,"marketCap":1433128992},{"date":"2025-02-07","current":11.238302,"twenty":10.0243,"median":11.162591,"eighty":13.191014,"marketCap":1546012440},{"date":"2025-02-14","current":11.154484,"twenty":10.062805,"median":11.126814,"eighty":12.776093,"marketCap":1533742500},{"date":"2025-02-21","current":12.73316,"twenty":10.073062,"median":11.193598,"eighty":12.735779,"marketCap":1757055408},{"date":"2025-02-28","current":11.508443,"twenty":10.189099,"median":11.508443,"eighty":12.653552,"marketCap":1582822260},{"date":"2025-03-07","current":12.084413,"twenty":10.276651,"median":11.554796,"eighty":12.584056,"marketCap":1668711840},{"date":"2025-03-14","current":12.91496,"twenty":10.28916,"median":11.611229,"eighty":12.584056,"marketCap":1784049276},{"date":"2025-03-21","current":12.244709,"twenty":10.311241,"median":11.810026,"eighty":12.735779,"marketCap":1690797732},{"date":"2025-03-28","current":11.696332,"twenty":10.344738,"median":11.831112,"eighty":12.72799,"marketCap":1734969516},{"date":"2025-04-03","current":10.807781,"twenty":10.395616,"median":11.800074,"eighty":12.674918,"marketCap":1600000176},{"date":"2025-04-11","current":9.828764,"twenty":10.27298,"median":11.65378,"eighty":12.589531,"marketCap":1445398932},{"date":"2025-04-17","current":9.988361,"twenty":10.075173,"median":11.569961,"eighty":12.56072,"marketCap":1472392800},{"date":"2025-04-25","current":10.079541,"twenty":10.050182,"median":11.463659,"eighty":12.511173,"marketCap":1487116728},{"date":"2025-05-02","current":10.290636,"twenty":10.067013,"median":11.287756,"eighty":12.494061,"marketCap":1467484824},{"date":"2025-05-09","current":10.406872,"twenty":10.062805,"median":11.203375,"eighty":12.472285,"marketCap":1494478692},{"date":"2025-05-16","current":10.339488,"twenty":10.073062,"median":11.154484,"eighty":12.457737,"marketCap":1496932680},{"date":"2025-05-23","current":10.443848,"twenty":10.076938,"median":11.100884,"eighty":12.429027,"marketCap":1516564584},{"date":"2025-05-30","current":10.499086,"twenty":10.079206,"median":11.063697,"eighty":12.408842,"marketCap":1531288512},{"date":"2025-06-06","current":10.405237,"twenty":10.102813,"median":10.92653,"eighty":12.402573,"marketCap":1521472560},{"date":"2025-06-13","current":16.776007,"twenty":10.127345,"median":11.063697,"eighty":12.429027,"marketCap":2453988000},{"date":"2025-06-20","current":13.783342,"twenty":10.148232,"median":11.100884,"eighty":12.535947,"marketCap":2012270160},{"date":"2025-06-27","current":13.241991,"twenty":10.175286,"median":11.154484,"eighty":12.72799,"marketCap":1938650520},{"date":"2025-07-04","current":14.247042,"twenty":10.191457,"median":11.198369,"eighty":12.80722,"marketCap":2085889800},{"date":"2025-07-11","current":16.12378,"twenty":10.199228,"median":11.287756,"eighty":13.164345,"marketCap":2358282468},{"date":"2025-07-18","current":16.959198,"twenty":10.204599,"median":11.508443,"eighty":13.325525,"marketCap":2478527880},{"date":"2025-07-25","current":16.429296,"twenty":10.22327,"median":11.606189,"eighty":13.872228,"marketCap":2409816216},{"date":"2025-08-01","current":16.329429,"twenty":10.25109,"median":11.703755,"eighty":14.068336,"marketCap":2380368360},{"date":"2025-08-08","current":17.296232,"twenty":10.27298,"median":11.825546,"eighty":14.242565,"marketCap":2527607640},{"date":"2025-08-15","current":25.546022,"twenty":10.28665,"median":12.04207,"eighty":14.454008,"marketCap":3727607772},{"date":"2025-08-22","current":27.152477,"twenty":10.291424,"median":12.068084,"eighty":15.48419,"marketCap":3646626168},{"date":"2025-08-29","current":24.186548,"twenty":10.297713,"median":12.158366,"eighty":16.326447,"marketCap":3263804040},{"date":"2025-09-05","current":26.17651,"twenty":10.31224,"median":12.214209,"eighty":16.547432,"marketCap":3528834744},{"date":"2025-09-12","current":23.22216,"twenty":10.322989,"median":12.270192,"eighty":16.690567,"marketCap":3136196664},{"date":"2025-09-19","current":21.82033,"twenty":10.32445,"median":12.326094,"eighty":16.958366,"marketCap":2944785600},{"date":"2025-09-26","current":20.564467,"twenty":10.331172,"median":12.407292,"eighty":17.223519,"marketCap":2768098464},{"date":"2025-10-03","current":22.006879,"twenty":10.341379,"median":12.455816,"eighty":17.606421,"marketCap":2969325480},{"date":"2025-10-10","current":19.015463,"twenty":10.348945,"median":12.489783,"eighty":18.310381,"marketCap":2561963472},{"date":"2025-10-17","current":16.970486,"twenty":10.358786,"median":12.586793,"eighty":18.134776,"marketCap":2284662828},{"date":"2025-10-24","current":16.253675,"twenty":10.405237,"median":12.724544,"eighty":17.900127,"marketCap":2188957296},{"date":"2025-10-31","current":15.392522,"twenty":10.406545,"median":12.739707,"eighty":17.871014,"marketCap":2076073848},{"date":"2025-11-07","current":13.654382,"twenty":10.406872,"median":12.862233,"eighty":17.830642,"marketCap":1840491000},{"date":"2025-11-14","current":13.652109,"twenty":10.414705,"median":13.150654,"eighty":17.669327,"marketCap":1845398976},{"date":"2025-11-21","current":13.022772,"twenty":10.429703,"median":12.977364,"eighty":17.532486,"marketCap":1759509396},{"date":"2025-11-28","current":14.151953,"twenty":10.441671,"median":13.150654,"eighty":17.476552,"marketCap":1919018616},{"date":"2025-12-05","current":15.0671,"twenty":10.446315,"median":13.212896,"eighty":17.360095,"marketCap":2046625992},{"date":"2025-12-12","current":15.021249,"twenty":10.450076,"median":13.373682,"eighty":17.303573,"marketCap":2044172004},{"date":"2025-12-19","current":13.906512,"twenty":10.4562,"median":13.596735,"eighty":17.18567,"marketCap":1896932724},{"date":"2025-12-24","current":13.468772,"twenty":10.460694,"median":13.541362,"eighty":17.140598,"marketCap":1842944988},{"date":"2026-01-02","current":13.594612,"twenty":10.472165,"median":13.526709,"eighty":17.103787,"marketCap":1867484868},{"date":"2026-01-09","current":14.184539,"twenty":10.508332,"median":13.623361,"eighty":17.043007,"marketCap":1953374448},{"date":"2026-01-16","current":15.82386,"twenty":10.552044,"median":13.654647,"eighty":16.970089,"marketCap":2186209278},{"date":"2026-01-23","current":17.221546,"twenty":10.59039,"median":13.760784,"eighty":17.043007,"marketCap":2377029620},{"date":"2026-01-30","current":18.645413,"twenty":10.66635,"median":13.818506,"eighty":17.208843,"marketCap":2585326030},{"date":"2026-02-06","current":17.570145,"twenty":10.791312,"median":13.890789,"eighty":17.500019,"marketCap":2442411318},{"date":"2026-02-13","current":16.566637,"twenty":10.808038,"median":13.930604,"eighty":17.447639,"marketCap":2316142276},{"date":"2026-02-20","current":15.898541,"twenty":10.808553,"median":13.936612,"eighty":17.405456,"marketCap":2219535716},{"date":"2026-02-27","current":15.400942,"twenty":10.876548,"median":13.991046,"eighty":17.345071,"marketCap":2173647600},{"date":"2026-03-06","current":14.146009,"twenty":10.927529,"median":14.014987,"eighty":17.323365,"marketCap":1980434480},{"date":"2026-03-13","current":13.445786,"twenty":10.970802,"median":13.989227,"eighty":17.304533,"marketCap":1891073412},{"date":"2026-03-20","current":14.324288,"twenty":11.037013,"median":13.985049,"eighty":17.25142,"marketCap":2007001284},{"date":"2026-03-27","current":13.721414,"twenty":11.063706,"median":13.970301,"eighty":17.198531,"marketCap":1917640216},{"date":"2026-04-02","current":10.613398,"twenty":11.02367,"median":13.933608,"eighty":17.173124,"marketCap":1671293488},{"date":"2026-04-10","current":10.730025,"twenty":10.921534,"median":13.908042,"eighty":17.15803,"marketCap":1702690620},{"date":"2026-04-17","current":10.908083,"twenty":10.807781,"median":13.879703,"eighty":17.114449,"marketCap":1731672588},{"date":"2026-04-24","current":10.496724,"twenty":10.72787,"median":13.842971,"eighty":17.099223,"marketCap":1666463160},{"date":"2026-04-30","current":10.935086,"twenty":10.702023,"median":13.783342,"eighty":17.068754,"marketCap":1736502916},{"date":"2026-05-08","current":10.594139,"twenty":10.67921,"median":13.733566,"eighty":16.988616,"marketCap":1688199636},{"date":"2026-05-15","current":10.339602,"twenty":10.612541,"median":13.678484,"eighty":16.968896,"marketCap":1651972176},{"date":"2026-05-22","current":9.81785,"twenty":10.57772,"median":13.654515,"eighty":16.961058,"marketCap":1565026272},{"date":"2026-05-29","current":9.044003,"twenty":10.498141,"median":13.649387,"eighty":16.95795,"marketCap":1446683236},{"date":"2026-06-05","current":8.457984,"twenty":10.457266,"median":13.565546,"eighty":16.950392,"marketCap":1354907004},{"date":"2026-06-12","current":7.84515,"twenty":10.439494,"median":13.517899,"eighty":16.945188,"marketCap":1255885280},{"date":"2026-06-18","current":9.015379,"twenty":10.406872,"median":13.501167,"eighty":16.890943,"marketCap":1446683236},{"date":"2026-06-26","current":8.75713,"twenty":10.374116,"median":13.445786,"eighty":16.79658,"marketCap":1398379956},{"date":"2026-07-03","current":9.944532,"twenty":10.341471,"median":13.381214,"eighty":16.771208,"marketCap":1589177912},{"date":"2026-07-10","current":9.593587,"twenty":10.324058,"median":13.25487,"eighty":16.748323,"marketCap":1531213976},{"date":"2026-07-17","current":9.016752,"twenty":10.293006,"median":13.217326,"eighty":16.724074,"marketCap":1444268072},{"date":"2026-07-24","current":7.64292,"twenty":10.258532,"median":13.162063,"eighty":16.679208,"marketCap":1224488148},{"date":"2026-07-31","current":8.064769,"twenty":10.200205,"median":13.05573,"eighty":16.651478,"marketCap":1294527904},{"date":"2026-08-07","current":7.771324,"twenty":10.158149,"median":12.918657,"eighty":16.626081,"marketCap":1249847370},{"date":"2026-08-14","current":8.113953,"twenty":10.118328,"median":12.875119,"eighty":16.619851,"marketCap":1306603724},{"date":"2026-08-21","current":7.572239,"twenty":10.071221,"median":12.803792,"eighty":16.5966,"marketCap":1231733640}],"updateTime":1787506121988},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02566\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624250432","title":"Hangzhou Jiuyuan Gene says CSRC clears H-share full circulation filing for 136.3 million shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2624250432","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624250432?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:15","pubTimestamp":1775135722,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering received a filing notice on April 2, 2026 covering its H-share full circulation plan.Filing completed for conversion of 136,302,015 unlisted shares held by 12 shareholders into H shares.Conversion must be completed within 12 months of filing notice date or filing materials must be updated to continue process.Next step targets application to Hong Kong Stock Exchange for listing and dealing permission for converted H shares.Implementation plan remains unfinished, with further updates expected as process advances.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDLb0jnN1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624548043","title":"Stable 10.6% Margin At Hangzhou Jiuyuan Genetic Biopharmaceutical Reinforces Bullish Valuation Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2624548043","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624548043?lang=en_us&edition=fundamental","pubTime":"2026-04-01 21:28","pubTimestamp":1775050139,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical (SEHK:2566) has put fresh FY 2025 numbers on the table, with first half revenue of C¥638.8 million and basic EPS of C¥0.37 setting the tone for how the year is shaping up. Over recent halves the company has seen revenue move from C¥702.4 million and EPS of C¥0.53 in 1H 2024 to C¥666.8 million and EPS of C¥0.16 in 2H 2024, giving investors a clear view of how the current run rate compares with recent history. With trailing 12 month net profit margins...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2566/hangzhou-jiuyuan-genetic-biopharmaceutical-shares/news/stable-106-margin-at-hangzhou-jiuyuan-genetic-biopharmaceuti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2566/hangzhou-jiuyuan-genetic-biopharmaceutical-shares/news/stable-106-margin-at-hangzhou-jiuyuan-genetic-biopharmaceuti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02566","BLSX","BLSG","BK4112","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153677162","title":"Stock Track | JIUYUAN GENE Plummets 5.08% Intraday on Weak FY25 Results with Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1153677162","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153677162?lang=en_us&edition=fundamental","pubTime":"2026-03-31 10:06","pubTimestamp":1774922812,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE's stock plummeted 5.08% during intraday trading on Tuesday, following the release of its full-year 2025 financial results which showed a decline in revenue.The company reported that...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111368780","title":"JIUYUAN GENE (02566) Proposes Appointment of Dr. Huang Wenli as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1111368780","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111368780?lang=en_us&edition=fundamental","pubTime":"2026-03-31 01:26","pubTimestamp":1774891577,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) announced that the board of directors has proposed the appointment of Dr. Huang Wenli as an independent non-executive director. The proposed appointment is set to take effect...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146619556","title":"JIUYUAN GENE (02566) Announces Annual Results: Profit Attributable to Owners Reaches RMB 138 Million, Proposes Final Dividend of RMB 0.57 per 10 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1146619556","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146619556?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:26","pubTimestamp":1774884380,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has released its annual results for the period ended December 31, 2025. The group reported revenue of RMB 1.306 billion. Profit attributable to owners for the year was RMB 138...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIG","BK4585","BK1161","02566","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145577533","title":"Jiuyuan Gene Updates Board Governance Framework with Revised Nomination Committee Charter Effective March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1145577533","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145577533?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:07","pubTimestamp":1774883266,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (“Jiuyuan Gene”, 02566) has released an updated “Terms of Reference of the Nomination Committee of the Board of Directors,” which will take effect...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623467813","title":"Hangzhou Jiuyuan Gene proposes final dividend of RMB 0.57 per 10 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2623467813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623467813?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:18","pubTimestamp":1774880289,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering proposed final dividend for year ended Dec. 31, 2025 of RMB 0.57 per 10 shares.Shareholders set to vote on proposal on June 15, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLrt0jc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623346499","title":"Hangzhou Jiuyuan FY25 revenue falls 4.6% to RMB 1.3 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2623346499","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623346499?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:12","pubTimestamp":1774879934,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene reported 2025 profit attributable to owners of RMB 138 million, little changed from a year earlier.Revenue slipped 4.6% to RMB 1.3 billion, driven mainly by lower orthopedic product sales amid DRGs/DIP reforms and online listing-related price cuts.Gross margin widened 1.7 percentage points to 80.7% on lower raw material costs and lean production management.Two new products launched in 2025: Jixinfen generated RMB 11 million in sales, while Jilixin contributed RMB 2 million.For 2026, strategy targets a portfolio centered on innovative drugs and biopharmaceutical-device combinations, with metabolic pipelines including JY54  and JY54-2 .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL6FQgmc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162272003","title":"Jiuyuan Gene targets 31.13% public float through 136.30 million-share H-share conversion","url":"https://stock-news.laohu8.com/highlight/detail?id=1162272003","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162272003?lang=en_us&edition=fundamental","pubTime":"2026-03-25 16:40","pubTimestamp":1774428048,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has detailed a concrete timetable to resolve its public-float shortfall by converting 136.30 million unlisted domestic shares held...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622025777","title":"Hangzhou Jiuyuan Gene Engineering; public float rises to about 31.13% due to planned H-share full circulation pending CSRC filing notice by end-April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622025777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622025777?lang=en_us&edition=fundamental","pubTime":"2026-03-25 16:39","pubTimestamp":1774427993,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering; public float rises to about 31.13% due to planned H-share full circulation pending CSRC filing notice by end-April 2026. Hangzhou Jiuyuan Genetic Biopharmaceutical said it expects to receive a filing notice from the China Securities Regulatory Commission by end-April 2026 for its H-share full circulation plan.The proposal would convert 136.3 million unlisted shares held by 12 shareholders into H shares, lifting public float to about 31.13% and restoring compliance with the minimum prescribed percentage.After the filing notice, the company plans to complete required procedures in 2Q2026, subject to regulatory reviews and approvals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene En","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL34tnvd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164747939","title":"JIUYUAN GENE Withdraws 2026 Share Award Scheme Resolutions and Cancels 8 Apr Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1164747939","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164747939?lang=en_us&edition=fundamental","pubTime":"2026-03-25 12:21","pubTimestamp":1774412486,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE) announced on 25 March 2026 that its board has withdrawn all resolutions related to the proposed 2026 Share Award Scheme. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186435048","title":"Jiuyuan Gene (02566.HK) Sets 30 Mar 2026 Board Meeting for FY2025 Results and Dividend Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1186435048","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186435048?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:21","pubTimestamp":1773829312,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene, 02566.HK) has scheduled a board meeting for Monday, 30 March 2026. The agenda comprises:   1. Reviewing and approving the audited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620234980","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical to hold board meeting on 2025 audited results and final dividend proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2620234980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620234980?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:15","pubTimestamp":1773828911,"startTime":"0","endTime":"0","summary":"Jiuyuan Gene said its board will meet on March 30, 2026 to consider and approve the audited results for the year ended Dec. 31, 2025. The board will also consider a recommendation on a final dividend at the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLbFrSdh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128209026","title":"JIUYUAN GENE's JY47 Injection Receives Implied Clinical Trial Approval from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1128209026","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128209026?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:26","pubTimestamp":1773739577,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has announced that the Investigational New Drug (IND) application for its independently developed JY47 injection has received implied approval for clinical trials from China's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181125783","title":"Jiuyuan Gene (02566) Secures NMPA IND Approval for SIRPα-Targeting JY47 Injection in MASH with Liver Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=1181125783","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181125783?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:23","pubTimestamp":1773739385,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene, 02566) disclosed that China’s National Medical Products Administration (NMPA) has cleared the Company’s investigational new drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620405974","title":"Hangzhou Jiuyuan Gene Engineering wins NMPA clinical trial approval for JY47 injection IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2620405974","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620405974?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:19","pubTimestamp":1773739190,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene said China’s National Medical Products Administration granted clinical trial approval for its JY47 Injection under an investigational new drug application. The monoclonal antibody targets SIRPα and is intended for metabolic dysfunction-associated steatohepatitis with liver fibrosis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL29jTnK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620544053","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy47 Injection Ind Application Obtains Clinical Trial Approval From Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2620544053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620544053?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:19","pubTimestamp":1773739179,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN40508D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618628454","title":"Hangzhou Jiuyuan Gene Engineering Co. Ltd. Announces Extraordinary General Meeting Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2618628454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618628454?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:27","pubTimestamp":1773055656,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering will hold an extraordinary general meeting in Hangzhou on April 8, 2026. Shareholders will vote on adopting a 2026 Share Award Scheme. They will also vote on authorizing the board and/or an authorized person to handle matters relating to the scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL1sCVrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105183238","title":"JIUYUAN GENE (02566) Reports February 2026 Share Repurchases and Updated Public Float","url":"https://stock-news.laohu8.com/highlight/detail?id=1105183238","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105183238?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712216,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) disclosed that as of February 28, 2026, total registered share capital remained at RMB 245.40 million, with no change in the numbers of authorized or issued Domestic Shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126651865","title":"JIUYUAN GENE (02566) Releases February 2026 Monthly Return on Equity Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1126651865","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126651865?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:49","pubTimestamp":1772617764,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE, Stock Code: 02566) published its monthly return for equity movements as of 28 February 2026. The company reported no changes in its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":85,"code":"91000000","status":"200"}]}}